O
Orbita
Software to improve patient engagement in digital healthcare through voice-first and conversational ai solutions
About Orbita
Orbita.ai operates in the healthcare technology market, providing a conversational AI platform designed to enhance patient engagement and streamline interactions between patients and healthcare providers. The company's core product includes HIPAA-compliant virtual assistants that mirror human behavior to effectively serve patients, healthcare providers, payers, and life sciences companies. Orbita's solutions are designed to create, manage, and optimize conversational experiences, offering tools such as Orbita Experience Designer, Orbita Answers, and Orbita Insights. These tools enable users to build complex question and answer interactions, gain actionable insights, and create omnichannel, multimodal solutions that improve the patient journey.
Orbita's business model is based on a subscription service, where clients pay for access to the platform and its various features. The company generates revenue through these subscriptions as well as through additional services such as customization and support. Orbita serves a diverse range of clients within the healthcare sector, including hospitals, insurance companies, and pharmaceutical firms. By leveraging AI technology, Orbita aims to improve patient outcomes, reduce operational costs, and enhance the overall efficiency of healthcare delivery.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Boston, United States
- Employees
- 62
- Open positions
- None listed
- Dealroom signal
- 72.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Core AI, Hard Tech, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Nanotech, IoT InternetOfThings
- Client focus
- b2b
- Investment activity
- 1 company, latest May 2018
- Capital deployed
- $0
- Preferred round
- SEED
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AEquity / VC | Feb 2023 | $4.3M | $17M | HealthX Ventures | — |
| SERIES A✓Equity / VC | May 2020 | $9M | $36M | Newark Venture Partners · Cultivation Capital · HealthX Ventures · Philips Ventures | ↗ |
Growth signals
Latest recorded traffic for Orbita is 21K monthly website visits, up 195.8% over the last three months. Orbita's team grew 12.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
HealthX Ventures
Philips Ventures
Newark Venture Partners
Cultivation Capital
Other known investors3 additional known investors
MassChallenge
Brigham Innovation Hub
Philips Healthcare
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Orbita on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Orbita’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.